Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

To elucidate the cellular mechanism by which angiotensin II (ANG II) induces cardiac hypertrophy, we investigated the possible autocrine/paracrine role of endogenous endothelin-1 (ET-1) in ANG II-induced hypertrophy of neonatal rat cardiomyocytes by use of synthetic ET-1 receptor antagonist and antisense oligonucleotides to preproET-1 (ppET-1) mRNA. Northern blot analysis and in situ hybridization revealed that ppET-1 mRNA was expressed in cardiomyocytes, but, to a lesser extent, in nonmyocytes as well. ANG II upregulated ppET-1 mRNA level by threefold over control level as early as 30 min, and it stimulated release of immunoreactive ET-1 from cardiomyocytes in a dose- and time-dependent manner. ET-1 stimulated ppET-1 mRNA levels after 30 min in a similar fashion as ANG II. Tetradecanoylphorbol-acetate (10(-7) M) mimicked the effects of ANG II and ET-1 on induction of ppET-1 mRNA. ANG II-induced ppET-1 gene expression was completely blocked by protein kinase C inhibitor H-7 or by down-regulation of endogenous protein kinase C by pretreatment with phorbol ester. ET-1 and ANG II stimulated twofold increase [3H]leucine incorporation into cardiomyocytes, whose effects were similarly and dose dependently inhibited by endothelin A receptor antagonist (BQ123). Introduction of antisense sequence against coding region of ppET-1 mRNA into cardiomyocytes resulted in complete blockade with ppET-1 mRNA levels and [3H]leucine incorporation stimulated by ANG II. These results suggest that endogenous ET-1 locally generated and secreted by cardiomyocytes may contribute to ANG II-induced cardiac hypertrophy via an autocrine/paracrine fashion.

[1]  Y. Inada,et al.  [Nonpeptide angiotensin II receptor antagonists]. , 1993, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[2]  Y. Hirata,et al.  Induction of Endothelin‐1 Gene by Angiotensin and Vasopressin in Endothelial Cells , 1992, Hypertension.

[3]  T. Fukami,et al.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. , 1992, Life sciences.

[4]  L. Neyses,et al.  Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1. , 1991, Biochemical and biophysical research communications.

[5]  M. Brandi,et al.  Endothelin as an autocrine factor in the regulation of parathyroid cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Shichiri,et al.  Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. , 1991, Kidney international.

[7]  K. Chien,et al.  Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. , 1990, The Journal of biological chemistry.

[8]  T. Resink,et al.  Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. , 1990, Cell regulation.

[9]  K. Baker,et al.  Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. , 1990, The American journal of physiology.

[10]  Y. Mitsui,et al.  Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum‐free medium , 1990, FEBS letters.

[11]  J. Toulmé,et al.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids. , 1990, Biochimica et biophysica acta.

[12]  M. Shichiri,et al.  Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. , 1990, Biochemical and biophysical research communications.

[13]  L. Kedes,et al.  Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Yanagisawa,et al.  The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. , 1989, The Journal of biological chemistry.

[15]  Y. Hirata,et al.  Endothelin is a potent mitogen for rat vascular smooth muscle cells. , 1989, Atherosclerosis.

[16]  M. Shichiri,et al.  Concomitant secretion of big endothelin and its C-terminal fragment from human and bovine endothelial cells. , 1989, Biochemical and biophysical research communications.

[17]  M. Yanagisawa,et al.  A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. , 1989, The Journal of biological chemistry.

[18]  T. Masaki,et al.  The Human Preproendothelin‐1 Gene: Possible Regulation by Endothelial Phosphoinositide Turnover Signaling , 1989, Journal of cardiovascular pharmacology.

[19]  Y. Hirata,et al.  Binding and receptor down‐regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells , 1988, FEBS letters.

[20]  R. Tjian,et al.  Fos-associated protein p39 is the product of the jun proto-oncogene. , 1988, Science.

[21]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[22]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[23]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[24]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[25]  P. Khairallah,et al.  Effects of Angiotensin II on DNA, RNA and Protein Synthesis , 1972 .